Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.

類似資料

• Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191.
  著者:: Armstrong, R. A., 等
  出版事項: (1993)
• GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
  著者:: Lumley, P., 等
  出版事項: (1989)
• Effect of GR32191, a potent thromboxane receptor antagonist, on exercise induced bronchoconstriction in asthma.
  著者:: Finnerty, J P, 等
  出版事項: (1991)
• The pharmacodynamics and pharmacokinetics of a novel thromboxane receptor blocking drug vapiprost (GR32191) after single intravenous doses in healthy subjects.
  著者:: Thomas, M, 等
  出版事項: (1991)
• The haemodynamic effects of GR 32191, a thromboxane A2 receptor antagonist, in patients with renal artery stenosis and hypertension.
  著者:: Lyons, D, 等
  出版事項: (1993)